Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
Pharmaceutical and medical device manufacturers should be advised that the government is using its enforcement authority under the Open Payments Program (otherwise known as the Sunshine Act) in conjunction with the Anti-Kickback Statute (AKS) against manufacturers for alleged kickbacks paid to referring physicians.
CONTINUE READING ON www.natlawreview.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
